J&J Subsidiaries Fight Back Generic Challenge

Law360, New York (July 7, 2006, 12:00 AM EDT) -- Subsidiaries of Johnson & Johnson are suing a generic drug maker for patent infringement, hoping to block its attempts to market a generic version of a drug used to treat Alzheimer’s disease.

Janssen Pharmaceutica N.V., Janssen L.P., Ortho-McNeil Neurologics Inc. and Synaptech Inc. filed the lawsuit against Barr Pharmaceuticals and its subsidiary, Barr Laboratories Inc., a Delaware corporation that operates in New Jersey.

The lawsuit was triggered when Barr filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for a generic...
To view the full article, register now.